Lipid particles having asymmetric lipid coating and method of preparing same

• US 7,005,140 B2
• Filed: 03/30/2004
• Issued: 02/28/2006
• Est. Priority Date: 03/31/2003
• Status: Active Grant

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Zhang, Yuanpeng
• Primary Examiner(s): Ketter, James
• Assistant Examiner(s): Garvey, Tara L
• Application Number:
  US10/814,703
• Publication Number:
  US 20040191306A1
• Time in Patent Office: 700 Days
• Field of Search: 424/450, 514/44
• US Class Current: 424/450
• CPC Class Codes: A61K 47/6911 the form being a liposome
• CPC Class Codes: A61K 9/1271 Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers liposome as conjugate A61K47/6911
• CPC Class Codes: A61K 9/1272 with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids with cholesterol as the only non-phosphatidyl surfactant A61K9/127; lipids as modifying agent A61K47/543
• CPC Class Codes: A61K 9/1277 Processes for preparing; Proliposomes

Abstract

A method of preparing lipid particles having an asymmetric lipid coating is described. The lipid composition of the outer lipid coating of the particles varies from the inner to outer surfaces. The asymmetric lipid particles are formed by preparing a lipid composition containing a charged lipid and a therapeutic agent, where the particles each have an outer lipid coating with an external lipid leaflet and an internal lipid structure. The particles are then incubated under conditions effective to remove the charged lipid from the external lipid leaflet, thus rendering the lipid coating asymmetric. The particles have the ability to their regain surface charge via translocation of the lipids.

Claims

1. A method of preparing lipid particles having an external lipid coating, comprising:

preparing lipid particles comprised of (i) a lipid composition containing a charged lipid and (ii) a therapeutic agent, said particles each having an outer lipid coating having an external lipid leaflet and an internal lipid structure; and

incubating said particles in a medium and under conditions effective to remove said charged lipid from the external lipid leaflet into said medium.

2. The method of claim 1, wherein said preparing is comprised of preparing lipid particles composed of a lipid composition containing at least one cationic lipid.

3. The method of claim 1, wherein said preparing comprises (i) forming lipid vesicles composed of said lipid composition and (ii) complexing said lipid vesicles with said therapeutic agent.

4. The method of claim 1, wherein said incubating comprises incubating said lipid particles in a medium containing uncharged lipid vesicles.

5. The method of claim 4, wherein said incubating further includes adding to the medium a lipid-polymer-ligand conjugate.

6. The method of claim 1, wherein said lipid particles are liposomes.

7. The method of claim 6, wherein said incubating further includes adding to the medium a lipid derivatized with a hydrophilic polymer.

8. The method of claim 7 wherein said adding is comprised of adding a phospholipid derivatized with polyethyleneglycol.

9. The method of claim 1, wherein said incubating is at a temperature of less than about 15°

C.

10. The method of claim 1, wherein said incubating is for a time of greater than about 5 hours.

11. The method of claim 1, wherein said preparing is comprised of preparing lipid particles having an entrapped therapeutic agent selected from the group consisting of a charged drug, a protein, a peptide, and a nucleic acid.

12. The method of claim 11, wherein said therapeutic agent is a protein or peptide.

18. The method of claim 1, further comprising separating the lipid particles from said medium.

13. A method of preparing lipid particles having an asymmetric charged lipid composition in its outer lipid coating prior to in vivo administration, comprising:

preparing lipid particles comprised of (i) a lipid composition containing a charged lipid and (ii) a therapeutic agent, said particles each having an outer lipid coating having an external lipid leaflet and an internal lipid structure; and

incubating said particles in a medium and under conditions effective to remove charged lipids from the external lipid leaflet into said medium.

14. The method according to claim 13, wherein said incubating includes incubating at a temperature of less than about 15°

C.

15. The method according to claim 13, wherein said incubating includes incubating for a time of greater than about 5 hours.

16. The method according to claim 13, wherein said incubating includes incubating in a medium comprised of neutral lipid vesicles.

17. The method according to claim 13, further comprising separating the lipid particles from said medium.